Under the agreement, GoodRx will acquire the platform from TherapeuticsMD for $150 million, with an additional $7 million consideration contingent upon its financial performance through 2023.
The platform is designed to help patients understand their coverage and find savings opportunities for brand medications.
“Over the past decade, GoodRx has helped millions of Americans afford generic medications, but brand medications remain too expensive for too many people,” Doug Hirsch, co-CEO and co-founder of GoodRx, said in a March 7 news release. “With VitaCare, we aim to grow our reach and provide new tools for both consumers and providers to help ensure that more patients can access relevant savings programs and navigate prior authorization requirements.”
The deal is expected to close in mid-2022.
At the Becker's 11th Annual IT + Revenue Cycle Conference: The Future of AI & Digital Health, taking place September 14–17 in Chicago, healthcare executives and digital leaders from across the country will come together to explore how AI, interoperability, cybersecurity, and revenue cycle innovation are transforming care delivery, strengthening financial performance, and driving the next era of digital health. Apply for complimentary registration now.
